Adovate

Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which has enabled us to design patented compounds with favorable physiochemical characteristics (e.g., potency, selectivity, solubility) that historically limited adenosine molecules commercially.